DOJ Two Biotech Executives Charged in Securities Fraud Scheme Thomas Sullivan Feb 14, 2023 0 Two former executives were recently indicted for schemes to defraud investors in CytoDyn, Inc. The executives, Nader Pourhassan,…
CMS CMS Releases OPPS and ASC Payment System Final Rule Thomas Sullivan Feb 13, 2023 0 The Centers for Medicare & Medicaid Services (CMS) on November 1, 2022, released the calendar year 2023 Hospital Outpatient…
Drug Prices Brand-Name Prescription Drug Prices Continue to Fall Thomas Sullivan Feb 10, 2023 0 In 2022, brand-name prescription drug prices fell for the fifth consecutive year, despite media coverage to the contrary. Even…
Congress FDA Receives Increased Budget for FY 2023 Thomas Sullivan Feb 9, 2023 0 The omnibus spending bill passed by Congress in December 2023 includes funding and direction for the United States Food and Drug…
Medicare Health Affairs Releases Research on Value-Based Payment Models Thomas Sullivan Feb 8, 2023 0 Health Affairs recently published a research brief, Value-Based Payment As A Tool To Address Excess US Health Spending. The brief…
DOJ DOJ and DEA Announce $1.9 Million Settlement, Resolving Controlled… Thomas Sullivan Feb 7, 2023 0 Northeast Hospital Corporation has agreed to pay $1.9 million in civil penalties to resolve allegations that the hospital failed…
Medical Legal CVS and Walgreens Reach Settlement in Opioid Lawsuits Thomas Sullivan Feb 6, 2023 0 CVS and Walgreens have reached a settlement totaling more than $10 billion, settling allegations that the companies failed to…
CME Diversity, Equity, and Inclusion (DEI) Educational Sessions at ACEHP Annual… Thomas Sullivan Feb 3, 2023 0 Starting February 6-9, 2023, the Alliance for Continuing Medical Education in the Health Professions (ACEHP) will hold its…
Uncategorized $3.1 Billion Walmart Opioid Settlement Reaches Important Milestone Thomas Sullivan Feb 2, 2023 0 Walmart recently announced that it reached settlement agreements with all fifty states – as well as Puerto Rico, Washington, DC,…
FDA Congressional Report Released on FDA’s Improper Actions in Aduhelm Approval… Thomas Sullivan Feb 1, 2023 0 Following an 18-month investigation, House of Representatives Oversight and Reform Committee Chairwoman Carolyn Maloney and Energy…